Genetic contribution to multiple sclerosis risk among Ashkenazi Jews

BMC Medical Genetics

Volumn 16, Issue 1, 2015, Pages

  Khankhanian, Pouya ^a   Matsushita, Takuya ^a,b   Madireddy, Lohith ^a   Lizée, Antoine ^a   Din, Lennox ^a   Moré, Jayaji M ^a   Gourraud, Pierre Antoine ^a   Hauser, Stephen L ^a   Baranzini, Sergio E ^a   Oksenberg, Jorge R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Ashkenazi jews; Genome wide association study; Multiple sclerosis; Population genetics

Indexed keywords

HLA A ANTIGEN; HLA DRB1 ANTIGEN; HLA B38 ANTIGEN; HLA C ANTIGEN; HLA-A*68 ANTIGEN; HLA-C*12:03 ANTIGEN;

AFRICAN; ALLELE; ARTICLE; ASIAN; CONTROLLED STUDY; EUROPEAN; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEREDITY; HLA DRB1 GENE; HUMAN; JEW; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; POPULATION GENETICS; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; ETHNOLOGY; FAMILY; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MALE; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ALLELES; CASE-CONTROL STUDIES; FAMILY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HLA-A ANTIGENS; HLA-B38 ANTIGEN; HLA-C ANTIGENS; HUMANS; JEWS; MALE; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84937809955     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/s12881-015-0201-2     Document Type: Article

References (31)

1. Hauser SL, Goodin DS: Multiple Sclerosis and Other Demyelinating Diseases, 17th edition edn: McGraw Hill; 2010.
2. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology. 2008;71(2):129-35.
3. Sotgiu S, Pugliatti M, Sotgiu A, Sanna A, Rosati G. Does the "hygiene hypothesis" provide an explanation for the high prevalence of multiple sclerosis in Sardinia? Autoimmunity. 2003;36(5):257-60.
4. Granieri E, Casetta I, Govoni V, Tola MR, Marchi D, Murgia SB, et al. The increasing incidence and prevalence of MS in a Sardinian province. Neurology. 2000;55(6):842-8.
5. Alter M, Kahana E, Zilber N, Miller A. Multiple sclerosis frequency in Israel's diverse populations. Neurology. 2006;66(7):1061-6.
6. International Multiple Sclerosis Genetics Consortium (IMSGC), Wellcome Trust Case Control Consortium 2 (WTCCC2), Sawcer S, Hellenthal G, Pirinen M, Spencer CC, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476(7359):214-9.
7. International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013;45(11):1353-60.
8. Atzmon G, Hao L, Pe'er I, Velez C, Pearlman A, Palamara PF, et al. Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry. Am J Hum Genet. 2011;86(6):850-9.
9. Behar DM, Yunusbayev B, Metspalu M, Metspalu E, Rosset S, Parik J, et al. The genome-wide structure of the Jewish people. Nature. 2010;466(7303):238-42.
10. Hammer MF, Redd AJ, Wood ET, Bonner MR, Jarjanazi H, Karafet T, et al. Jewish and Middle Eastern non-Jewish populations share a common pool of Y-chromosome biallelic haplotypes. Proc Natl Acad Sci U S A. 2000;97(12):6769-74.
11. Klitz W, Gragert L, Maiers M, Fernandez-Vina M, Ben-Naeh Y, Benedek G, et al. Genetic differentiation of Jewish populations. Tissue Antigens. 2010;76(6):442-58.
12. Carmi S, Hui KY, Kochav E, Liu X, Xue J, Grady F, et al. Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins. Nat Commun. 2014;5:4835.
13. Kwon OJ, Karni A, Israel S, Brautbar C, Amar A, Meiner Z, et al. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch Neurol. 1999;56(5):555-60.
14. Tang H, Peng J, Wang P, Risch NJ. Estimation of individual admixture: analytical and study design considerations. Genet Epidemiol. 2005;28(4):289-301.
15. Karni A, Kahana E, Zilber N, Abramsky O, Alter M, Karussis D. The frequency of multiple sclerosis in Jewish and Arab populations in greater Jerusalem. Neuroepidemiology. 2003;22(1):82-6.
16. Karni A, Kohn Y, Safirman C, Abramsky O, Barcellos L, Oksenberg JR, et al. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel. Mult Scler. 1999;5(6):410-5.
17. Patsopoulos NA, Barcellos LF, Hintzen RQ, Schaefer C, van Duijn CM, Noble JA, et al. Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet. 2013;9(11):e1003926.
18. Amirzargar A, Mytilineos J, Yousefipour A, Farjadian S, Scherer S, Opelz G, et al. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients. Eur J Immunogenet. 1998;25(4):297-301.
19. Gourraud PA, Harbo HF, Hauser SL, Baranzini SE. The genetics of multiple sclerosis: an up-to-date review. Immunol Rev. 2012;248(1):87-103.
20. Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet. 2004;74(1):160-7.
21. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet. 2009;18(4):767-78.
22. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007;357(9):851-62.
23. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005;58(6):840-6.
24. Gusev A, Palamara PF, Aponte G, Zhuang Z, Darvasi A, Gregersen P, et al. The Architecture of Long-Range Haplotypes Shared within and across Populations. Mol Biol Evol. 2012;29(2):473-86.
25. Need AC, Kasperaviciute D, Cirulli ET, Goldstein DB. A genome-wide genetic signature of Jewish ancestry perfectly separates individuals with and without full Jewish ancestry in a large random sample of European Americans. Genome Biol. 2009;10(1):R7.
26. Nelson MR, Bryc K, King KS, Indap A, Boyko AR, Novembre J, et al. The Population Reference Sample, POPRES: a resource for population, disease, and pharmacological genetics research. Am J Hum Genet. 2008;83(3):347-58.
27. Price AL, Butler J, Patterson N, Capelli C, Pascali VL, Scarnicci F, et al. Discerning the ancestry of European Americans in genetic association studies. PLoS Genet. 2008;4(1):e236.
28. Browning BL, Browning SR. A fast, powerful method for detecting identity by descent. Am J Hum Genet. 2011;88(2):173-82.
29. Gower JC. Some distance properties of latent root and vector methods used in multivariate analysis. Biometrika. 1966;53:325-8.
30. Hartigan JA. Clustering Algorithms. New York: Wiley; 1975.
31. Gourraud PA, McElroy J, Caillier SJ, Johnson BA, Santaniello A, Hauser SL, et al. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Ann Neurol. 2011;69(1):65-74.